Harrow, Inc. (HROW) stock
HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
$29.52+0.43 (+1.48%)
Close on Nov 17, 2026Market cap $1.11BP/E –Yield –
Harrow price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Harrow's price to sales ratio was 4.0× on Nov 11, 2026, against 6.2× a year earlier. Over the last 5 years it ranged from 2.3× to 10.4×, with a median of 4.8×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 4.0× | −3.3 |
| 2025 | Dec 31, 2025 | 7.3× | +0.2 |
| 2024 | Dec 31, 2024 | 7.1× | +3.6 |
| 2023 | Dec 29, 2023 | 3.4× | −1.1 |
| 2022 | Dec 30, 2022 | 4.5× | +1.0 |
| 2021 | Dec 31, 2021 | 3.5× | −0.3 |
| 2020 | Dec 31, 2020 | 3.8× | −0.2 |
| 2019 | Dec 31, 2019 | 3.9× | +0.5 |
| 2018 | Dec 31, 2018 | 3.5× | +2.1 |
| 2017 | Dec 29, 2017 | 1.4× | −0.5 |
| 2016 | Dec 30, 2016 | 1.9× | −8.0 |
| 2015 | Dec 31, 2015 | 9.9× | −52.4 |
| 2014 | Dec 31, 2014 | 62.3× | – |
See a number that looks wrong?